BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.

Jove - Journal of Visualized Experiments, with ISSN 1940-087X, is a pioneering journal dedicated to publishing high-quality visualized research across a diverse array of scientific disciplines, including biochemistry, genetics, molecular biology, chemical engineering, immunology, microbiology, and neuroscience. Established in 2006 and published by the Journal of Visualized Experiments, this journal plays a crucial role in advancing research methodologies by allowing scientists to share their experimental procedures through visual means, thereby enhancing reproducibility and accessibility. With a Q2 classification in Chemical Engineering and several Q3 rankings in related fields as of 2023, Jove serves as a vital resource for researchers looking to disseminate complex experimental techniques clearly and effectively. Although the journal operates under traditional access models, it is committed to fostering an open exchange of knowledge, making it invaluable for students, professionals, and researchers eager to stay at the forefront of scientific innovation.

EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.

EXPERIMENTAL BIOLOGY AND MEDICINE is a distinguished open-access journal published by FRONTIERS MEDIA SA, specializing in the interdisciplinary fields of biochemistry, genetics, and medicine. With an ISSN of 1535-3702 and an E-ISSN of 1535-3699, this journal presents a robust platform for cutting-edge research and innovative clinical studies. Since its inception in 1996, it has evolved to feature a broad scope that caters to the evolving needs of researchers, professionals, and students, ensuring a dynamic dissemination of knowledge in biological and medical sciences. In 2023, the journal achieved a notable Q2 ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories, reflecting its strong impact and relevance within the academic community, as supported by its Scopus rank of #59 out of 221 in general biochemistry and genetics, placing it in the 73rd percentile. By offering open access options, EXPERIMENTAL BIOLOGY AND MEDICINE aims to maximize the reach and visibility of research findings, fostering collaboration and knowledge sharing across global audiences. Researchers are encouraged to contribute to this vital resource as it continues to advance the understanding of biological mechanisms and therapeutic approaches crucial for modern medicine.

Cell Reports Methods is a cutting-edge journal published by CELL PRESS, focusing on innovative methodologies in the vast fields of biochemistry, genetics, biotechnology, and radiological sciences. Launched in 2021, it has rapidly ascended to attain a Q1 ranking across multiple disciplines in the latest 2023 metrics, reflecting its influential contribution to the scientific community. With an emphasis on practical and rigorous experimental approaches, this journal serves as a vital resource for researchers looking to advance their methodologies and collaborate on significant findings in their respective specialties. Despite not being an open-access publication, Cell Reports Methods ensures broad accessibility through institutional subscriptions, allowing researchers from various backgrounds to engage with high-quality scholarly work. The journal presents a unique platform for sharing insights from interdisciplinary methods that foster innovation and discovery, ultimately shaping the future of scientific research.

STAR Protocols, published by Elsevier, is an esteemed open access journal that has been at the forefront of providing innovative experimental protocols since its inception in 2020. With a distinct focus on a range of scientific disciplines including Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology, and Neuroscience, this journal serves as a vital resource for researchers, professionals, and students alike. The journal holds a commendable status, reflected by its Q1 and Q2 rankings across various relevant categories, ensuring the dissemination of high-impact research methods and findings. With its open access format, STAR Protocols encourages a broad readership and facilitates the sharing of pivotal knowledge in the scientific community, driving forward the culture of transparency and collaboration in research. Positioned in the vibrant academic landscape of the United States, it steadily contributes to the evolution of experimental methodologies, fostering innovation across disciplines.

JOURNAL OF HISTOTECHNOLOGY, published by Taylor & Francis Ltd, is a leading academic journal dedicated to advancing the field of histotechnology, which plays a crucial role in both clinical and research settings. With an established history since 1977, this journal serves as a critical platform for researchers, professionals, and students engaged in the intricate study of tissue processing, staining techniques, and microscopic analysis. It is currently indexed in reputable databases, reflecting its commitment to scientific rigor, with a notable presence in categories such as Anatomy, Histology, and Medical Laboratory Technology. Despite its open access status being limited, the Journal of Histotechnology maintains a respectable impact factor and ranks within the third quartile for Anatomy and Medical Laboratory Technology, and fourth quartile for Histology in 2023, emphasizing its relevance in the scholarly community. As the field continues to evolve, this journal aims to foster innovation and dissemination of knowledge within histotechnology, making it an essential resource for those looking to further their expertise and contribute to the advancements in this vital area of health sciences.

Data in Brief is an esteemed open-access journal published by Elsevier that has been at the forefront of disseminating valuable and succinct research findings since its inception in 2014. With a focus on multidisciplinary and educational data, the journal serves as a vital platform for researchers, professionals, and students seeking quick access to high-quality data papers that complement larger research articles. Notably, Data in Brief holds a commendable rank of #40 out of 171 in the multidisciplinary category, placing it in the 76th percentile, which underscores its relevance and impact within the academic community. Operating with an open-access model, it ensures that research is readily available to a global audience, facilitating collaboration and innovation across various fields. The journal's commitment to providing a rich repository of easily digestible data makes it an essential resource for anyone interested in enhancing their research or knowledge base.

International Journal of Biomedicine, published by INT MEDICAL RESEARCH & DEVELOPMENT CORP, is a premier Open Access journal dedicated to advancing knowledge in the multifaceted fields of biomedicine, including but not limited to biochemistry, genetics, immunology, microbiology, and neuroscience. With its ISSN 2158-0510 and E-ISSN 2158-0529, this journal has been serving as a significant platform for researchers since its inception in 2011, ensuring the dissemination of high-quality, peer-reviewed articles. Despite currently holding a Q4 ranking in prominent categories such as Biochemistry, Genetics and Molecular Biology and Neuroscience, the journal plays a vital role in fostering scientific dialogue and innovation in these rapidly evolving domains. The journal's commitment to accessibility further empowers both seasoned professionals and budding scholars to contribute to, and benefit from, the wealth of research that characterizes the biomedicine landscape. With a significant emphasis on interdisciplinary approaches and contemporary issues, the International Journal of Biomedicine is an essential resource for those aiming to navigate the complex intersections of health, disease, and biomedical discovery.

Revista Romana de Medicina de Laborator is a prominent open-access journal published by SCIENDO, dedicated to the field of medical laboratory technology and biochemistry. Since its inception, this journal has been a vital platform for disseminating research findings and advancements in laboratory medicine. With an ISSN of 1841-6624 and E-ISSN 2284-5623, it has served the academic community since 2008 and has embraced an open-access model since 2013, ensuring that valuable research is accessible to all. While it features niche rankings in Scopus for areas such as Medical Laboratory Technology and Clinical Biochemistry, it consistently strives to engage researchers, professionals, and students. Its rich collection of articles highlights innovative techniques and methodologies, supporting the ongoing development of laboratory practices. Although its coverage in Scopus has been discontinued, the journal continues to publish high-quality studies that contribute significantly to the field, fostering knowledge exchange essential for advancing medical science.